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Abstract
Background: Genesis of acquired epilepsy includes transformations spanning genetic-to-
network-level modifications, disrupting the regional excitatory/inhibitory balance. Methodology 
concurrently tracking changes at multiple levels is lacking. Here, viral vectors are used to 
differentially express two opsin proteins in neuronal populations within dentate gyrus (DG) of 
hippocampus. When activated, these opsins induced excitatory or inhibitory neural output that 
differentially affected neural networks and epileptogenesis. In vivo measures included behavioral 
observation coupled to real-time measures of regional glutamate flux using ceramic-based 
amperometric microelectrode arrays (MEAs).
Results: Using MEA technology, phasic increases of extracellular glutamate were recorded 
immediately upon application of blue light/488 nm to DG of rats previously transfected with an 
AAV 2/5 vector containing an (excitatory) channelrhodopsin-2 transcript. Rats receiving twice-
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daily 30-sec light stimulation to DG ipsilateral to viral transfection progressed through Racine 
seizure stages. AAV 2/5 (inhibitory) halorhodopsin-transfected rats receiving concomitant 
amygdalar kindling and DG light stimuli were kindled significantly more slowly than non-
stimulated controls. In in vitro slice preparations, both excitatory and inhibitory responses were 
independently evoked in dentate granule cells during appropriate light stimulation. Latency to 
response and sensitivity of responses suggest a degree of neuron subtype-selective functional 
expression of the transcripts.
Conclusions: This study demonstrates the potential for coupling MEA technology and 
optogenetics for real-time neurotransmitter release measures and modification of seizure 
susceptibility in animal models of epileptogenesis. This microelectrode/optogenetic technology 
could prove useful for characterization of network and system level dysfunction in diseases 
involving imbalanced excitatory/inhibitory control of neuron populations and guide development 
of future treatment strategies.
Keywords
Dentate gyrus; Epileptogenesis; Glutamate; Microelectrode array; Optogenetics
1. Introduction
The precise mechanisms that drive epileptogenesis are unknown. Clearly, there are many 
potential triggering events. Changes occur over time at many levels of organization, 
including genetic alterations, molecular and biochemical modifications, alterations of 
channels and neurotransmission, morphologic and cellular reorganization, and network 
transformations (Klein et al., 2018). Which of these processes is transcendent and whether 
any singular modification represents a common node for the multiple causations ultimately 
leading to the behavioral expression of spontaneous seizures is unknown. Regardless, 
acquired epilepsy, the product of the process of epileptogenesis, is associated with increased 
likelihood of pathological hyper-synchronous activation of large populations of neurons that 
may occur through imbalanced secretion of both excitatory (glutamate) and inhibitory 
(GABA) neurotransmitters. Understanding the contribution of cellular excitability to the 
process of epileptogenesis will be critical for developing disease-modifying therapies to 
prevent the development of acquired epilepsy.
Specific, targeted control of neural systems to establish causality between neuronal activity 
and behavior has remained difficult to achieve until recent technological advances, including 
optogenetics, which introduces light sensitive proteins (opsins) into neurons that regulate 
transmembrane ion conductance (Boyden et al., 2005; Deisseroth et al., 2015). The most 
common opsins in use modulate membrane potentials, including blue light (488 nm)-
activated channelrhodopsin (ChR2, excitation) and yellow light (593 nm)-activated 
halorhodopsin (NpHR, hyperpolarization) (Govorunova et al., 2015; Nagel et al., 2003). 
Most studies to date have reported the ability of opsin transfection to modify behavior and 
ex vivo synaptic function and some have investigated targeting of different opsin promoters 
to differing neuron subpopulations (Khoshkhoo et al., 2017). Here, amperometric glutamate 
microelectrode recordings, immunolabeling, whole cell patch-clamp electrophysiology, and 
behavioral responses to electrical kindling were used to investigate targeting of different 
Butler et al. Page 2
Epilepsy Res. Author manuscript; available in PMC 2020 August 27.
V
A
 A
uthor M
anuscript
V
A
 A
uthor M
anuscript
V
A
 A
uthor M
anuscript
opsins to glutamatergic and GABAergic neuronal populations within the hippocampus, 
using a single adenoviral serotype. This multipronged, temporal approach allows network, 
neuronal, and presynaptic release changes to be linked to biochemical, anatomical, 
electrophysiological, and behavioral outcomes associated with epileptogenesis. The 
functional and behavioral outcomes of transfecting these opsins is discussed.
2. Materials and methods
2.1. Viral construct and hippocampal viral injections
The viral vectors used in this study were pseudotyped AAV2/5 vectors, where the transgene 
of interest is flanked by inverted terminal repeats of the AAV2 packaged in an AAV5 capsid. 
The AAV vectors were produced using a double-transfection method with the plasmid 
(pAAV-hSyn-hChR2(H134R)-EYFP or pAAV-hSyn-NpHR3.0-EYFP) and the appropriate 
helper plasmid containing the essential adenoviral packaging genes, as previously described 
(Ulusoy et al., 2009). The final titers of the injected AAV vector suspensions were between 
2.4e +14 and 2.8e+14 genome copies/mL.
All animal procedures were approved by the University of Kentucky Institutional Animal 
Care and Use Committee. Male Sprague-Dawley rats (Harlan Laboratories, Indianapolis, IN, 
U.S.A.) were used for these experiments. At 18–24 weeks of age, rats were anesthetized 
with isoflurane (1–3 %) and placed in a stereotaxic frame. A midline incision was made on 
the scalp to expose the skull. A burr hole was made above the dentate gyrus (DG) of the 
hippocampus (from bregma: AP: −4.4 mm; ML: −2.2 mm; Paxinos and Watson, 2005). A 
Hamilton syringe was loaded with 1 μL of the channelrhodopsin (488 nm; blue light 
activation; pAAV-hSyn-hChR2(H134R)-EYFP) or halorhodopsin (593 nm; yellow light 
activation; pAAV-hSyn-NpHR3.0-EYFP) suspension (in PBS) and was lowered to the DG 
(DV: −4.0) where the suspension was slowly injected over 4 min. The tissue was allowed to 
rest for 5 min before the needle was slowly retracted. Five to 7 weeks was allowed before 
experimentation was started to allow for near maximal expression of the vector to occur 
(Zhang et al., 2010).
2.2. In vivo amperometric measures of glutamate using microelectrode assemblies 
(MEAs)
Amperometric recordings, (100 kHz data acquisition displayed at a display frequency of 10 
Hz), were performed using the FAST16mkIII recording system (Fast Analytical Sensing 
Technology, Quanteon, LLC, Nicholasville, KY). Ceramic-based Microelectrode arrays 
(MEAs) consisting of four platinum (Pt) recording sites measuring 15 × 333 μm arranged 
vertically in dual pairs (S2 conformation) were configured to measure glutamate as 
previously described (Burmeister et al., 2013). Briefly, a solution of 1 % Glutamate-oxidase 
(GluOx; US Biological, Salem, MA), 1 % bovine serum albumin (BSA; Sigma-Aldrich, St. 
Louis, MO) and 0.125 % glutaraldehyde (Glut; Sigma-Aldrich), was prepared and coated 
onto the bottom pair of recording sites to allow for the conversion of glutamate to α-
ketoglutarate and the reporter molecule, H2O2, which can be oxidized at the surface of the Pt 
with an applied potential of +0.7 V vs Ag/AgCl. The top pair of recording sites, or the 
sentinel sites, only received a coating of the BSA/Glut matrix. This coating configuration 
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allows for background measures and subtraction to obtain a self-referenced glutamate signal 
for measures of both tonic and phasic glutamate (Burmeister et al., 2013; Burmeister and 
Gerhardt, 2001). To make the electrode even more specific for glutamate and to eliminate 
electroactive interfering molecules such as ascorbic acid and dopamine from reaching the Pt 
sites, 1,3-phenylenediamine (mPD), a molecular size exclusion layer, was electroplated onto 
all 4 Pt recording sites (Burmeister et al., 2013). Before in vivo use, an in vitro calibration 
was used to determine selectivity (glutamate vs. ascorbic acid), sensitivity (slope, in nAmps/
μM), and limit of detection (in μM based on a signal-to-noise ratio of 3), as previously 
described (Burmeister et al., 2013).
2.3. MEA and optical fiber configuration
For this study, the transfected channelrhodopsin (ChR2) was stimulated locally by affixing a 
guide cannula (Plastics One Roanoke VA) to the MEA. A fiber optic cannula (Ø200 μm 
Core, 0.39 NA; Thorlabs, Newton, NJ) was then inserted through the guide with the tip of 
the fiber positioned ∼ 200 μm from the surface of the MEA in between all 4 Pt sites (see Fig. 
1). The laser source (OBIS LS 488 nm, 100 mW, Coherent, Santa Clara, CA) was controlled 
through its analog port using a Master-8 pulse generator (A.M.P.I., Jerusalem, Israel). Pulse 
trains (100 pulses, 40 Hz) with variable pulse durations (1–20 ms) generating light 
intensities between 1–20 mW or constant light stimulation of variable intensities (1–50 mW) 
was delivered locally through the fiber optic cannula.
2.4. Electrical kindling
Fourteen-week-old male Sprague-Dawley rats (Harlan Laboratories) had stimulating 
electrodes surgically implanted in the right amygdala [from bregma: AP, 2.8; ML, +4.8; DV, 
8.5; nose bar, 3.3 (flat skull)] as previously described (Matveeva et al., 2007). Animals were 
each tested for their after discharge (AD) threshold prior to kindling. An S88 dual channel 
stimulator (Grass Technologies, West Warwick, RI, U.S.A.) delivered a 1 s train of biphasic 
square wave pulses (1 ms pulse duration, 60 Hz) starting at an initial 100 μA until an AD 
was recorded on electroencephalography (EEG); this AD threshold was used for subsequent 
stimulation. About one third of animals exhibited no behavioral activity, and two-thirds 
experienced facial clonus (stage 1) or head nodding (stage 2) at their established AD 
threshold. Animals were housed individually in an enriched environment and maintained on 
a 12 h light/dark cycle with food and water available ad libitum. For amygdala kindling, rats 
that had received an injection of NpHR were also affixed with a waveguide cannula (Ø200 
μm Core, 0.39 NA; Thorlabs, Newton, NJ) targeted in the DG and received a light 
stimulation (∼ 2–3 sec duration; 593 nm; ∼50 mW; LaserGlow technologies) immediately 
before the start of the kindling stimulus (1 s).
ChR2 “kindling”: Some ChR2 injected animals were implanted with a waveguide cannula 
(Ø200 μm Core, 0.39 NA; Thorlabs, Newton, NJ) targeted to the DG. Animals were 
stimulated (30 s) with a blue light laser at 50 mW power (OBIS LS 488 nm, Coherent, Santa 
Clara, CA). Unless specifically stated, all animals were stimulated twice daily, 5 days per 
week, until they experienced two consecutive Racine stage 5 seizures (tonic–clonic activity 
with loss of postural control/falling (Racine, 1972)).
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2.5. Slice preparation
Slices used for electrophysiological studies were obtained from rats 6 weeks after viral 
inoculation (i.e., 24–30 weeks of age). Rats were deeply anesthetized by isoflurane 
inhalation (5 %) and decapitated while anesthetized. The brain was removed and placed in 
ice-cold (2–4 °C) oxygenated artificial cerebrospinal fluid (ACSF) containing, in mM: 124 
NaCl, 3 KCl, 2 CaCl2, 26 NaHCO3, 1.3 MgCl2, 11 glucose and 1.4 NaH2PO4 equilibrated 
with bubbling 95 % O2−5 % CO2 (pH 7.2–7.4). Brains were blocked and glued to a 
sectioning stage, and 350 μm-thick slices were cut in the coronal plane in cold, oxygenated 
ACSF using a vibrating microtome (Vibratome Series 1000; Technical Products 
International, St. Louis, MO). Slices were transferred to a chamber containing oxygenated 
ACSF at 32–34 °C, where they were equilibrated for at least one hour prior to recording. 
Slices of the septal hippocampus were used in these experiments from viral injected rats and 
comparable slices from saline injected rats.
2.6. Whole cell recordings
Coronal hippocampal slices containing the dorsal third of the dentate gyrus were transferred 
to a recording chamber on an upright, fixed-stage microscope equipped with infrared, 
differential interference contrast optics (i.e., IR-DIC; Olympus BX50WI), where they were 
perfused with continuously warmed (32–34 °C) ACSF. Recordings were performed from 
dentate granule cells as described previously (Boychuk et al., 2016; Butler et al., 2015, 
2016; Butler et al., 2017). Recording pipettes were pulled from borosilicate glass (1.65 mm 
outer diameter, 0.45 mm inner diameter; King Precision Glass, Claremont, CA) with a P-87 
puller (Sutter Instrument, Novato, CA). The intracellular solution contained (in mM): 130 K
+-gluconate, 1 NaCl, 5 EGTA, 10 HEPES, 1 MgCl2, 1 CaCl2, 3 KOH, and 2 ATP. Open tip 
series resistance was 2–5 MOhms. Recordings were obtained using an Axon 700B amplifier 
(Molecular Devices), low-pass filtered at 6 kHz, digitized at 20 kHz with a Digidata 1550A 
(Molecular Devices), and acquired and analyzed using pClamp 10.5 programs (Clampfit, 
Molecular Devices). Cells were voltage-clamped at −65 mV for recordings of excitatory 
postsynaptic currents (EPSCs; ChR2 = 10 cells from 5 rats, NpHR = 8 cells from 5 rats) or 0 
mV for recordings of inhibitory postsynaptic currents (IPSCs; ChR2 = 5 cells from 3 rats) 
for 5–10 min to allow equilibration of pipette and intercellular solutions prior to data 
collection. Recordings were made from one cell in a slice, so cell and slice numbers are 
equivalent. Optical stimulation of the dentate gyrus was performed using 488 nm light for 
ChR2 stimulation and 593 nm light for NpHR stimulation. Three stimulation durations were 
used to test activation of the opsins (16 ms, 50 ms, and 500 ms). Following recording of 
responses to optical activation, either tetrodotoxin (TTX; 2 μM; Tocris Bioscience; 
Minneapolis, MN) to block action potentials, kynurenic acid (1 mM; Sigma Aldrich; St. 
Louis, MO) to block EPSCs, or bicuculline methiodide (30 μM; Tocris Bioscience; 
Minneapolis, MN) to block IPSCs was added to the circulating ACSF.
2.7. Analysis of 7SComplex
7S Complex was measured from synaptosomal extracts as previously described in detail 
(Matveeva et al., 2007, 2012a; Matveeva et al., 2012b, 2008; Matveeva et al., 2003).
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2.8. Statistical analysis
2.8.1. Electrophysiology data analysis—Electrophysiology data analysis was 
performed using Graphpad Prism software (Graphpad Software; La Jolla, CA), using one-
way ANOVA followed by Tukey’s post hoc tests. Unless otherwise indicated, data are 
expressed as mean ± SEM, and significance was set at p < 0.05.
2.8.2. Microelectrode array analysis—Raw amperometric glutamate release data and 
event markers were analyzed using custom exported MatLab-based software, to determine 
maximum amplitude, exponential rate of signal decay (k-1), uptake rate (k-1*amp, 
glutamate only), peak or trough area, rise/drop time (Trise/drop), and time for 80 % of signal 
decay (T80), as we have previously described (Ledo et al., 2017; Stephens et al., 2011, 
2014). Grouped results of single comparisons of these metrics were tested for normality with 
the Shapiro-Wilk normality test and analyzed using repeated measures analysis of variance 
(ANOVA with Bonferroni post-hoc) or a two-tailed Student’s t-test when data were normally 
distributed. The Wilcoxon signed rank test for paired samples or the Mann-Whitney U test 
for unpaired samples was used when normally-distributed population responses could not be 
established.
3. Results
3.1. Distribution of opsins
Viral vector injections vary as to distribution of the targeted expression from the injection 
site. In this study we found that unilateral injection of ChR2 and NpHR not only resulted in 
expression within the ipsilateral dentate gyrus neurons but also spread to the contralateral 
hemisphere, likely from the commissural projections associated with hippocampal mossy 
cells and pyramidal neurons. Transfection of ChR2 resulted in widespread labeling of both 
principal cells and interneurons (Fig. 2). In addition, transfection of NpHR in the rat dentate 
gyrus resulted in co-immunolabeling primarily with GABAergic neurons, consistent with 
electrophysiological results (Fig. 2, also see Figs. 5, 6 and 7). We have evaluated the 
durability and longevity of both ChR2 and NpHR proteins. Electrophysiological responses 
to light stimulation in hippocampal slices (Figs. 4–6) remained robust for up to 15 weeks 
following viral inoculation, supported by continued demonstration of the GFP reporter 
protein out to 15 weeks. This range encompassed the duration of the experiments.
3.2. Light-induced glutamate release
Action potential generation in glutamatergic neurons results in the release of glutamate in 
the synaptic cleft between the pre- and postsynaptic neurons and spillover into the 
extracellular space, where it is largely inactivated by low affinity/high capacity uptake into 
glia. (Danbolt, 2001) In theory, when a large population of neurons fire synchronized action 
potentials, a large release of glutamate would be detected in the terminal region/extracellular 
space of that neuron population, but to date, very few studies have examined 
neurotransmitter release combined with optical stimulation. In this study we attached an 
optical fiber (200 μm o.d. ∼200 μm from the recording sites) to our ceramic-based Pt MEA, 
which was configured to directly record tonic and phasic glutamate release (Burmeister et 
al., 2002), and lowered the assembly into the DG.
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Fig. 3 shows precise optical control of glutamate release using variable light intensities (0.2 
mW–50 mW). There was clear indication that the amplitude of the glutamate release was 
dependently related to power and the duration of the light emission. Repeated stimulation at 
1 min intervals were extremely reproducible and did not show signs of tachyphylaxis. 
Furthermore, at equivalent power delivered at the tip of the fiber optic cannula (∼4 to 5 
mW), we did not observe significant differences in the amount of glutamate release whether 
using a light pulse train (20 ms, 40 Hz, for 2.5 s) or constant light activation (∼2.5 s). We 
observed a maximal signal plateau at around 50 mW (data not shown). Based on our 
previous experience with evoked release of glutamate this was likely due to two major 
factors: 1) the density of synapses proximal to the MEA and 2) the maximal amount of light 
dispersion in the brain, which for blue light (488 nm) is estimated at no more than 1 mm 
(Bernstein et al., 2008; Yizhar et al., 2011). Furthermore, the temporal dynamics of 
glutamate release produced by ChR2 activation were similar to what we have previously 
reported using other forms of stimulation (high potassium, drug induced or behavior) 
(Stephens et al., 2014; Hunsberger et al., 2015; Miller et al., 2015; Quintero et al., 2007; 
Thomas et al., 2012). The dose-response of the glutamate signals vs. light power seen from 
light activation had a wider dynamic range and precision than we have seen from other 
methods involving micropipette drug applications, electrical stimulation or behavioral 
activation (Burmeister et al., 2002; Hascup et al., 2010; Onifer et al., 2012). These results 
support the hypothesis that the ChR2-control of glutamate release was robust and precisely 
regulated by the light stimulus.
3.3. Electrophysiological outcomes of ChR2 and NpHR activity in dentate gyrus granule 
cells (DGCs)
Transfection of ChR2 in rat dentate gyrus resulted in prominent labeling of principal, 
presumably glutamatergic neurons as well as presumptive GABAergic interneurons. 
Transfection of NpHR in the rat dentate gyrus resulted in prominent co-immunolabeling 
with GABAergic neurons (Fig. 2B, C); hilar mossy cells were also likely transfected. The 
functional outcomes of optical stimulation are important to our understanding of how these 
neurons affect the dentate gyrus circuit. For this study, we used optical stimulation while 
recording from DGCs to assess the functional outcomes of transfection of these channels 
into the dentate gyrus of the hippocampus. Stimulation in slices from rats transfected with 
AAV2/5-Syn-ChR2-EYFP resulted in direct inward currents in the recorded DGCs, which 
exhibited an increase in charge transfer during 16 msec to 500 msec stimulation, with no 
stimulus time-related differences in peak amplitude (peak amplitude 16 ms stim = 143.73 ± 
46.99 pA, peak amplitude 50 ms stim = 160.62 ± 55.54 pA, peak amplitude 500 ms stim = 
152.37 ± 50.70 pA; one-way ANOVA, F(2,27) = 0.03, p = 0.97. In contrast, since responses 
were sustained during the light stimulus, the electrical charge over time (i.e., the charge 
transfer) dramatically increased as pulse width increased. This increase in charge transfer 
reached statistical significance during a comparison of the 16 msec and 500 msec pulse 
widths (charge transfer 16 msec stim = 1.12 ± 0.71 pC/pF, charge transfer 50 msec stim = 
2.00 ± 0.82 pC/pF, charge transfer 500 msec stim = 9.35 ± 3.67 pC/pF; one-way ANOVA, F 
(2,27) = 4.18, p = 0.03; Tukey’s post-hoc: p = 0.96, 16 msec stim vs 50 msec stim, p = 0.04, 
16 msec stim vs 500 msec stim, p = 0.07 50 msec stim vs 500 msec stim; n = 10 cells; Fig. 4 
A–C). Together, the relatively short latency to response, similarity of peak amplitudes, and 
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increased charge transfer with longer pulses suggest a direct activation of the recorded DGC, 
as opposed to a synaptic response (response latency = 17.17 ± 1.28 msec; Fig. 4D).
These findings prompted further assessment of direct versus synaptic responses by 
examining the sensitivity of the response to pharmacological blockade of synaptic receptors 
or sodium channels that are required for action potential-dependent neurotransmitter release. 
The large inward currents observed during activation of ChR2 were insensitive to both 
kynurenic acid and TTX in recorded DGCs (peak amplitude 16 ms stim = 96.82 ± 64.21 pA, 
peak amplitude 50 ms stim = 95.86 ± 62.23 pA, peak amplitude 500 ms stim = 96.79 ± 
61.62 pA; charge transfer 16 msec stim = 2.43 ± 1.76 pC/pF, charge transfer 50 msec stim = 
2.41 ± 1.70 pC/pF, charge transfer 500 msec stim = 8.70 ± 5.97 pC/pF; Two-way ANOVA, 
F(2,12) = 0.2821, p = 0.76; n = 5 cells; Fig. 4E–G), suggesting these currents were generated 
directly within the recorded granule cell, consistent with ChR2 expression in transfected 
DGCs. Small, transient inward currents (superimposed on the initial portion of the evoked 
inward currents) were sensitive to kynurenic acid or TTX, consistent with a separate 
glutamate receptor-mediated synaptic component in some neurons.
A subset of DGCs in ChR2 transfected animals were recorded while voltage-clamped at 0 
mV to isolate putative GABAA receptor-mediated inhibitory responses. Optical stimulation 
of ChR2 resulted in transient, large outward currents with no significant difference in peak 
amplitude between stimulation durations (peak amplitude: 16 msec stim = 244.63 ± 109.29 
pA; 50 msec stim = 246.73 ± 110.03 pA; 500 msec = 253.70 ± 112.08 pA; F(2,12) = 0.001, 
p = 0.99; n = 5 cells; Fig. 5 A, B). Peak amplitude of the outward current was therefore not 
directly related to stimulus duration. Unlike the inward currents evoked at −65 mV, the 
increase in light stimulation pulse width did not result in increased outward current charge 
transfer in recorded DGCs (charge transfer 16 msec stim = 5.04 ± 2.81 pC/pF; 50 msec stim 
= 5.47 ± 2.81 pC/pF; 500 msec stim = 6.33 ± 3.61 pC/pF; one-way ANOVA, F(2,12) = 0.04, 
p = 0.96). The response latency was longer than for excitatory events evoked by optical 
stimulation of ChR2 (response latency = 25.83 ± 4.50 msec; unpaired t-test (13) = 2.482, p = 
0.02; Fig. 5D). Evoked outward currents were sensitive to bicuculline (Fig. 5E), indicating 
they were mediated by GABAA receptor activation. This suggests that ChR2 transfection 
also occurred in inhibitory neurons that project to DGCs, and/or in hilar mossy cells that 
mediate feedforward, di-synaptic inhibition of DGCs, in addition to the glutamatergic DGCs 
themselves.
Optical activation of AAV2/5-Syn-NpHR-EYFP, however, resulted in GABAergic inhibition 
of DGCs, and no direct inhibition of the DGC membrane was detected. The outward 
currents generated after activation of NpHR exhibited increased amplitude as stimulus 
duration increased from 16 to 500 msec (peak amplitude 16 msec stim = 9.98 ± 0.91 pA; 50 
msec stim = 18.19 ± 2.98pA; 500 msec stim = 20.42 ± 3.13 pA; one-way ANOVA, F(2,21) 
= 4.64, p = 0.02; Tukey’s post hoc: p = 0.08 16 msec stim vs 50 msec stim, p = 0.02 16 msec 
stim vs 500 msec stim, p = 0.81 50 msec stim vs 500 msec stim; n = 8 cells; Fig. 6 A,B). 
Similarly, charge transfer also increased with longer stimulus pulse widths (charge transfer 
16 msec stim = 0.05 ± 0.01 pC/pF; 50 msec stim = 0.13 ± 0.03 pC/pF; 500 msec stim = 0.18 
± 0.03 pC/pF; one-way ANOVA, F(2,21) = 7.34, p = 0.004; Tukey’s post hoc: p = 0.07, 16 
msec stim vs 50 msec stim; p = 0.003, 16 msec stim vs 500 msec stim; p = 0.30, 50 msec 
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stim vs 500 msec stim; Fig. 6C). Rather than being evoked at the onset of the stimulus, 
outward currents evoked by activating NpHR developed immediately after the light stimulus 
offset. The latency from the light stimulus offset to outward current onset was similar to that 
for synaptic responses evoked after activation of inhibitory neurons by ChR2 (onset latency 
= 24.81 ± 1.36 msec, Fig. 6D). This suggested they resulted from the removal of the 
inhibitory NpHR stimulus. The light-evoked outward currents were also sensitive to 
bicuculline (Fig. 6E), indicating they were mediated by GABAA receptors and consistent 
with rebound from NpHR-mediated inhibition of local inhibitory GABA neurons that 
projected to the recorded DGCs. These data are consistent with immunolabeling, which 
demonstrated a predominant NpHR transfection into GABAergic neurons (Fig. 2).
3.4. Behavioral responses to ChR2- and NpHR-optogenetic stimulation
Five rats were transfected with ChR2 injected into DG. After 6 weeks, they received twice-
daily stimuli with 50 mW blue light. Two developed Racine Stage 1 seizures with seven 
stimuli before pulling off their MEA pedestals. One rat progressed to Stage 2 after 27 stimuli 
and one to Stage 3 after 15 stimuli. Finally, one rat had two consecutive Stage 5 seizures 
with the 18th and 19th stimuli. Stimulus-induced release of neurotransmitter from synaptic 
vesicles is facilitated by docking to and fusion of the vesicle membrane with the presynaptic 
plasma membrane, mediated by integral membrane proteins called SNAREs. In neurons, the 
7S SNARE complex (7SC) is minimally required for vesicle/plasma membrane fusion 
(Weber et al., 1998); formation of stable 7SC is believed to represent one of the last steps 
before membrane fusion and is thus a hallmark of synaptic vesicles that are in a “ready-
release” state. The 7SC hippocampal ipsilateral/contralateral ratio of the rat that experienced 
two consecutive Stage 5 seizures was 1.28, consistent with enhanced stimulus-induced 
synaptic transmission and consistent with our studies of fully electrically kindled rats 
stimulated from diverse sites (Matveeva et al., 2007, 2012a; Matveeva et al., 2012b, 2008; 
Matveeva et al., 2003).
We also evaluated the effect of yellow light stimulation of NpHR to supress epileptogenesis 
in the kindling model (Fig. 7). Nine rats were DG-transfected with NpHR. After 5 weeks, 
rats were implanted with kindling electrodes into right basal amygdala and a guide cannula 
for the fiber optic cable into right DG. One week later, rats (n = 5) were then stimulated 
twice/day: yellow light was applied for 2–3 sec followed immediately by a 1 s kindling 
stimulation at the predetermined after-discharge threshold, such that laser stimulation 
temporally overlapped kindling stimulation. Controls (n = 4) received only the 1 s kindling 
stimulation twice/day. Optogenetically inhibited rats required more stimuli to achieve stage 
4/5 seizures than controls (p < 0.03) or historical controls from our laboratory (Matveeva et 
al., 2007, 2012a; Matveeva et al., 2008) and the literature (Le and La Salle, 1981).
4. Discussion
We aimed to determine how optogenetically-mediated neural network changes promote or 
inhibit hippocampal epileptic network activity and epileptogenesis. Although this study did 
not aim to determine specific component mechanisms at hierarchies below the network 
level, results provide important information on how the evolution of a pathologic network 
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can be enhanced or impeded by altering neuronal activity. Further, studies directed at the 
hierarchical level of network interactions may augment interpretation of outcomes from 
reductionist studies that are typically used to identify specific anatomic, molecular, or 
genetic mechanisms. Notably, hierarchical relationships are not necessarily linear and 
therefore prediction of network or system behavior as a function of changes in cell-type 
specific activity is inherently uncertain, and understanding epileptogenic network activity is 
therefore informative for understanding effects of cell-type specific pathologies. It is also 
important in the context of developing translationally relevant therapies for complex, multi-
hierarchical disorders like epilepsy that involve cellular, network, and system pathologies.
Serotype-specific adeno-associated viruses (AAV) can be used to transfect cells in vivo via 
stereotaxic injection. Selective neurotropism of specific AAV serotypes can help delimit 
transfection and choice of promoters can restrict expression of the opsin protein. Thus, this 
technique, utilizing a highly focal light stimulus to limit the area of activated opsins, allows 
for considerable cell type specificity with high temporal and spatial precision. The extent of 
viral spread and cell tropism can be quite different among serotypes, dependent on target 
tissue and species. We used a recombinant AAV2/5 serotype, that is, the vectors contain 
AAV2 terminal repeats flanking the opsin-recorder cassette under the control of the 
synuclein promoter in an AAV5 capsid. This serotype has been shown to transfect almost the 
entire rostral to caudal extent of the dorsal hippocampal formation, including the DG 
granule cell layer and neurons within the entire pyramidal layer in the CA1-CA3 region 
(Burger et al., 2004), consistent with our observations (Fig. 2). The AAV5 capsid, which 
binds sialic acid on the cell surface and uses platelet-derived growth factor (PDGFR) for 
entry (Di Pasquale et al., 2003; Walters et al., 2001), restricts recorder (GFP) expression to 
neurons when used with the SynI neuronal synapsin promoter (Kugler et al., 2003; 
Shevtsova et al., 2005). Data presented here indicate that AAV serotype 2/5 at the titer range 
we used transfects excitatory and inhibitory neurons in the hippocampal formation.
Several promoters have been intensively studied (Burger et al., 2004; Holehonnur et al., 
2014; Watakabe et al., 2015). α-Calcium/calmodulin-dependent kinase II (αCamKII) and 
SynI are most commonly used for neuronal transfection. Both promoters differentially 
transfect multiple neuronal types: GFP reporter is seen in both parvalbumin-positive GABA 
neurons and in large excitatory pyramidal cells independent of several AAV serotypes and 
using either neuronal promoter, but the expression levels of the transduced neurons is 
variable Watakabe et al., 2015). Interestingly, Nathanson et al. reported that both SynI and 
αCamKII promoters in an AAV1 serotype demonstrated an excitatory/inhibitory preference 
that changed by titer of the viral solution. (Nathanson et al., 2009) Differential levels of 
expression in at least two neuronal types may explain the electrophysiological data we 
present here. In this regard, it is well recognized that relatively small numbers of 
hippocampal GABA neurons, as demonstrated in Fig. 2B and C, can drive an excitatory 
synchronous volley and inhibiting restricted numbers of GABA neurons can increase evoked 
seizure threshold and shorten seizure duration (Khoshkhoo et al., 2017; Smith, 2013; 
Yekhlef et al., 2015).
The apparent spread of virus we observed (Fig. 2) helps ensure a wide regional, if not 
homogenous, level of expression among neurons. The cell-preferring but not cell-specific 
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neurotropism of our AAV2/5 serotype helps delimit transfection to neurons, and our choice 
of promoter restricts expression of the opsin protein but does not alter constitutive cellular 
function. Because of the apparent (and fortuitous) differential expression of these channels 
among cell types, this model system with a single transfection vector is uniquely positioned 
to amplify and perturb both excitatory and inhibitory circuits that participate in network 
changes associated with acquired epileptogenesis. These characteristics can be exploited to 
optogenetically induce (gain-of-function) or inhibit (loss-of-function) epileptogenesis and 
relate these effects to network change, and to specific behavioral, cellular, 
electrophysiological and molecular outcomes. This system is especially useful in isolating 
the role of network activity in epileptogenesis, as only those cells expressing the particular 
opsin exposed to the correct wavelength of light will respond. Other factors like cell death of 
vulnerable neuron populations or robust mossy fiber sprouting that are observed in animal 
models of epilepsy are less likely to occur in this system (Shibley and Smith, 2002; Winokur 
et al., 2004).
Electrical kindling paradigms using amygdala, perforant path, or hippocampus as the 
stimulation site all require considerably fewer stimuli to reach full kindling than we 
observed using our optogenetic technique (Matveeva et al., 2007). Stimulation sites external 
to and direct electrical stimulation of the dentate gyrus result in a large synchronous 
depolarization volley arising there and a presumed more rapid conversion to pathological 
epileptiform networks. We postulate that use of our technique results in a smaller initial 
region of synchronization, a longer interval to recruit additional neuronal populations, and a 
slower development of necessary network changes as observed in our behavioral study. Such 
slowed development is reminiscent of focal epileptogenesis that develops after stroke and 
other focal injuries (Hunt et al., 2013; Kelly et al., 2001). Optogenetic kindling may allow 
for more controlled study of cellular, electrophysiological, and network changes of 
epileptogenesis, analogous to optogenetics employed in studies of seizure initiation and 
maintenance (Khoshkhoo et al., 2017; Ye and Kaszuba, 2017).
Interestingly, not only did the transfection of the AAV2/5 viral vectors used in this study 
differ in neuron populations that were transfected, but also the functional outcome of these 
opsins was also distinct at the cellular and network levels. ChR2 transfection led 
predominantly to direct activation of the recorded DGCs that was largely unresponsive to 
kynurenic acid or TTX application; small, transient evoked inward currents superimposed on 
the principal response were sensitive to kynurenic acid and were therefore consistent with 
activation of excitatory synaptic terminals. This function is consistent with the ChR2 
transfection of glutamatergic principal neurons and glutamatergic synaptic terminals on the 
recorded neurons. ChR2 transfection of local, GABAergic neurons was also evident, and 
bicuculline-sensitive IPSCs were evoked in DGCs, an effect that could be mediated by 
directly activating inhibitory interneurons or via a feedforward/feedback microcircuit. In 
contrast, the transfection of NpHR primarily co-labeled with GABAergic neurons, and the 
activation of this opsin resulted in a transient outward current at the conclusion of the light 
stimulus, which was blocked by addition of the GABAA receptor antagonist, bicuculline. 
The blockade of this response in the presence of bicuculline and latency of response after 
conclusion of the stimulus are both consistent with the targeting of this viral transfection to 
GABAergic neurons in the dentate gyrus. Responses were not tested in other principal cells 
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of the hippocampus (e.g., CA1 or CA3 pyramidal cells), and it remains possible that other 
hippocampal cell types will express the opsin and contribute to the inhibitory effect on 
kindling of NpHR activation. Interestingly, in optogenetically-evoked neocortical seizures, 
inhibitory neurons are recruited prior to excitatory neurons at seizure onset, and optogenetic 
inhibition of GABA neuron subtypes can inhibit seizure initiation or duration, possibly via 
disinhibition of local GABA circuitry (Khoshkhoo et al., 2017). Further studies to identify 
transfection prevalence in subpopulations of hippocampal GABA neurons may be beneficial 
in the use of this opsin to study the process of acquired epileptogenesis, including after TBI, 
stroke, and CNS infection. The demonstrated feasibility of optogenetic stimulation to alter 
neuronal circuit and system function in vivo and ex vivo shows promise for modifying 
epileptogenesis, but specific neural circuit interactions should also be assessed in the context 
of these behavioral and neural network outcomes as studies and trials move forward.
To date, little work has been done using optogenetic techniques to study epileptogenesis and 
the associated network changes. Previous work in optogenetic activation of brain regions has 
demonstrated the ability to evoke or suppress seizures or seizure-like activity (Armstrong et 
al., 2013; Krook-Magnuson et al., 2013; Paz et al., 2013; Sukhotinsky et al., 2013). 
However, this study is the first to use in vivo real time measurement of glutamate with 
MEAs to assess the outcome of optical stimulation in transfected rodents (Parrot et al., 
2015). Detection of glutamate release that is sensitive to both stimulation frequency and 
duration demonstrates the ability of these opsins to respond to variable stimuli and potentials 
as an adaptable response, which in these studies was epileptogenesis or its hindrance.
In a review, Chow and Boyden proposed that optogenetics be used as a therapeutic 
intervention in conditions for which a clear benefit may be obtained from switching on or off 
specific cell types, and for which there is no better alternative. (Chow and Boyden, 2013) 
Examples included retinitis pigmentosa, epilepsy, and spinal cord injury. Optogenetic 
therapeutics currently require the delivery of genetic constructs by means of a viral vector 
and once inside the body, bacterial or algal opsins may need to be stably expressed for 
weeks, months or even years, and this could trigger an adaptive glial or immune response. 
That said gene therapy for Parkinson’s disease using AAV vectors has been advancing for 
the last decade, with continued refinements as knowledge advances. A recent clinical trial 
reported no clinically meaningful adverse events attributable to intraputaminal AAV2-
neurturin, indwelling for up to two years. (Olanow et al., 2015) Instrumentation such as 
Deep Brain Stimulation electrodes for Parkinson’s disease, Essential Tremor and dystonias 
(FDA-approved since 1999) and Vagal Nerve Stimulation for epilepsy (FDA-approved in 
2005) can be safely implanted and function for years. Preclinical studies using optogenetic 
approaches to develop new therapeutics to affect brain disorders are in process.
Optogenetic stimulation to drive behavioral alteration has been successfully implemented 
using in vivo electrophysiological monitoring methods. Using opsin-transfected 
hippocampal cells, Krook-Magnuson et al. have used a closed-loop system to record real-
time epileptiform activity in hippocampus and stop spontaneous temporal lobe seizures by 
light stimulation (Krook-Magnuson et al., 2013). A similar closed-loop paradigm has been 
used by Paz et al. to optogenetically control thalamus and interrupt seizures after cortical 
injury. (Paz et al., 2013) However, to our knowledge few studies have been reported that 
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connect optogenetic stimulation to neuronal activation by monitoring neurotransmitter 
concentrations. Microdialysis allows direct measurements of neurotransmitter output in 
response to optogenetic stimulation, but does not provide the necessary high spatial and 
temporal resolution required to study the rapid phasic activity of glutamate (or other 
neurotransmitter) release (Zant et al., 2016). In vivo amperometry using MEAs, however, 
does allow for quantification of extracellular neurotransmitter levels at the temporal and 
spatial resolution of electrophysiologic recordings. As shown here and elsewhere, this 
method allows for real-time measurement of both phasic and tonic glutamate release. 
(Matveeva et al., 2012a; Stephens et al., 2014; Batten et al., 2017; Viereckel et al., 2016) A 
real-time electrochemical recording device has been used to study optogenetically controlled 
dopamine release in PC12 cell cultures (Chiu et al., 2014) and striatum of anesthetized rat 
(Bass et al., 2010), and acetylcholine in rat basal forebrain (Gritton et al., 2016). The 
measurements of glutamate using optogenetics coupled to the MEA technology in this study 
are an extension of the recently reported studies by Viereckel and colleagues in the mouse 
globus pallidus. (Viereckel et al., 2018) Viereckel and coworkers used viral injection into the 
subthalamic nucleus to produce a selective expression of channelrhodopsin via glutamate 
fibers to the globus pallidus. Light activation of the globus pallidus adjacent to the MEA 
produced rapid and transient overflow of glutamate that was light intensity-dependent. 
(Viereckel et al., 2018) In the present studies, we used a different viral construct that 
targeted neurons into the dentate gyrus of the rat hippocampus to produce channelrhodopsin 
expression in the hippocampal trisynaptic pathway. Optical stimulation of ChR2 produced 
transient release of glutamate somewhat analogous to the work of Viereckel and coworkers. 
However, there were two major differences observed not withstanding we used a different 
viral construct with a synapsin promotor and a different viral serotype. First, our light-
evoked signals were very reproducible and were different in signal shape. Secondly, in 
comparison to Viereckel et al., our laser light pulses did not produce any photovoltaic effect 
or artifacts when the recording assembly was tested in vitro and we observed visible artifacts 
in the hippocampus of treatment naïve rats only at light intensities < 10 mW. The artifact/
photovoltaic effects were different in shape and time course from those described by 
Viereckel and coworkers and were easily removed using the self-referencing sentinel sites. 
Thus, no correction was needed for calculation of the glutamate concentrations as seen in 
Viereckel et al. (Viereckel et al., 2018) Some of these differences are likely due to the 
different viral constructs employed in the two different studies, the orientation of the MEA 
to the optical fiber and the different brain regions studied.
5. Conclusions
This study demonstrates the integration of transfected opsin channels into a rodent model 
with both in vivo and ex vivo functional outcome measures. Coupled with MEA real-time 
monitoring, these findings will provide a foundation for better understanding of how neuron 
population activity selectively contributes to disease progression and upon which future use 
of optogenetic interventions to modify neurological diseases, including epilepsy, can be 
based. Treatments affecting individual components of the disorder (e.g., GABA receptor 
modulators, sodium channel blockers) have failed to prevent epileptogenesis, even though 
clearly they can be effective against seizures. This proof of principle study indicates that 
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modifying activity at the network level can modify aspects of the epileptogenic process. 
These findings may provide valuable insight for novel therapy development, and will inform 
future, more reductionist approaches aimed at functionally relevant aspects of the network-
driven disease modification.
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Fig. 1. 
MEA with attached fiber optic cannula and glass pipette.
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Fig. 2. 
Distribution of Transfected AAV Constructs. A. ChR2-YFP expression in DG (10X) 
showing bilateral distribution of AAV2/5–CHR2-hSyn-EYFP in the hippocampus 6 weeks 
after a single injection (1 μl) into the right DG. B. AAV2/5-hSyn-NpHR 3.0-EYFP 
transfection (EYFP, green) and GAD67 immunolabeling (red) in the DG of a different rat 
(10X). There is a predominant colocalization of EYFP and GAD67 label, consistent with 
preferential transfection of GABAergic, inhibitory neurons. C. Enlargement of the boxed 
area in B, centered on a co-labeled hilar interneuron.
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Fig. 3. 
Light intensity dependent increases in glutamate release. Blue laser-induced release of 
glutamate in rat DG using MEA + waveguide array. Comparison of pulse trains (100 pulses) 
with variable pulse durations vs. constant blue laser activations. A range of 0.2–50 mW laser 
intensities were used to produce reproducible light intensity-dependent, increases in 
extracellular glutamate.
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Fig. 4. 
Channelrhodopsin (ChR2)-activated inward currents in dentate granule cells. A. 
Representative recording of response in dentate granule cell (DGC) held at −65 mV to blue 
light in rat transfected with ChR2. B. Bar graph of peak amplitude of responses to ChR2 
activity at 3 stimulation durations 16 msec, 50 msec, and 500 msec. C. Bar graph of charge 
transfer normalized to whole cell capacitance measures for direct ChR2 activity at 16 msec, 
50 msec, and 500 msec durations. D. Bar graph of latency to peak response following blue 
light onset. E. Representative trace of recorded DGC response to blue light in the presence 
of kynurenic acid and tetrodotoxin in circulating ACSF. F. Bar graph of peak amplitude 
responses of DGCs in nACSF and ACSF with kynurenic acid and tetrodotoxin added. G. Bar 
graph of charge transfer normalized to whole cell capacitance in DGCs recorded in nACSF 
and ACSF with kynurenic acid and tetrodotoxin added. Data represented as mean ± SEM. * 
p < 0.05.
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Fig. 5. 
ChR2 stimulation elicited GABAA receptor-mediated inhibitory synaptic responses in 
DGCs. A. Representative trace of response in DGC held at 0 mV to blue light in rat 
transfected with ChR2. B. Bar graph of peak amplitude of responses to ChR2 activity at 3 
stimulation durations 16 msec, 50 msec, and 500 msec. C. Bar graph of charge transfer 
normalized to whole cell capacitance measures for direct ChR2 activity at 16 msec, 50 msec, 
and 500 msec durations. D. Bar graph of latency to peak response following blue light onset. 
E. Representative trace demonstrating sensitivity of responses to bicuculline (30 μM). Data 
represented as mean ± SEM.
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Fig. 6. 
DGC responses to activation of halorhodopsin (NpHR). A. Representative trace of response 
in DGC held at −65 mV to blue light activity in rat injected with NpHR. Outward currents 
developed at the offset of the inhibitory stimulus. B. Bar graph of peak amplitude of 
responses to NpHR activity at 3 stimulation durations 16 msec, 50 msec, and 500 msec. C. 
Bar graph of charge transfer normalized to whole cell capacitance measures for direct ChR2 
activity at 16 msec, 50 msec, and 500 msec durations. D. Bar graph of latency to peak 
response following blue light offset. E. Representative trace demonstrating sensitivity of 
responses to bicuculline. Data represented as mean ± SEM. * p < 0.05.
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Fig. 7. 
Mitigation of epileptogenesis by expression and activation of halorhodopsin (NpHR). NpHR 
animals receiving overlapping yellow light activation (2–3 s) during 1-sec electrical 
stimulation of amygdala (yellow bar) required more stimuli (P < 0.03) to achieve stage 4/5 
seizures (21.4 ± 5.1 [SD]; n = 5) than those without light activation (green bar; 11.0 ± 5.4; n 
= 4) or historical non-transfected controls (Matveeva et al., 2007, 2012a; Matveeva et al., 
2008, 2003) (brown bar; 8.2 ± 3.1).
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